Stacey Honda

1.4k total citations
55 papers, 909 citations indexed

About

Stacey Honda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Stacey Honda has authored 55 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 9 papers in Epidemiology. Recurrent topics in Stacey Honda's work include Lung Cancer Diagnosis and Treatment (13 papers), Global Cancer Incidence and Screening (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Stacey Honda is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Global Cancer Incidence and Screening (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Stacey Honda collaborates with scholars based in United States, Switzerland and Japan. Stacey Honda's co-authors include Carlos N. Rios, Nadhipuram V. Bhagavan, Robert T. Greenlee, Debra P. Ritzwoller, Jinsheng Yang, Christine Neslund‐Dudas, Anil Vachani, Katharine A. Rendle, Chung‐Eun Ha and Andrea N. Burnett‐Hartman and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Stacey Honda

51 papers receiving 882 citations

Peers

Countries citing papers authored by Stacey Honda

Since Specialization

Citations

This map shows the geographic impact of Stacey Honda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Honda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Honda more than expected).

Fields of papers citing papers by Stacey Honda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacey Honda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Honda. The network helps show where Stacey Honda may publish in the future.

Co-authorship network of co-authors of Stacey Honda

This figure shows the co-authorship network connecting the top 25 collaborators of Stacey Honda. A scholar is included among the top collaborators of Stacey Honda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey Honda. Stacey Honda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer 2025 ·Cancer Epidemiology Biomarkers & Prevention ·Thomas E. Rohan, (unknown), (unknown), Fergus J. Couch, Robert T. Greenlee, Stacey Honda, Azadeh Stark, (unknown), Dhananjay Chitale, Xiaonan Xue, Mindy Ginsberg, Olivier Loudig	0
2	Host Environment, Genetics, and Behaviors That Contribute to Nontuberculous Mycobacterial Pulmonary Disease in Hawai'i 2025 ·American Journal of Respiratory and Critical Care Medicine ·Jennifer R. Honda, Arielle W. Parsons, (unknown), (unknown), Lin Ding, (unknown), (unknown), (unknown), (unknown), Jeffrey N. Myers, Vanessa Simiola, Stacey Honda, Edward D. Chan, Brian J. Reich, James Crooks, Michael Strong, Krishna Pacifici	0
3	Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study 2025 ·Breast Cancer Research and Treatment ·Thomas E. Rohan, Yihong Wang, Fergus J. Couch, Heather Spencer Feigelson, Robert T. Greenlee, Stacey Honda, Azadeh Stark, Dhananjay Chitale, (unknown), (unknown), Mindy Ginsberg, Olivier Loudig	1
4	Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice 2024 ·Annals of Internal Medicine ·Katharine A. Rendle, (unknown), Anil Vachani, Andrea N. Burnett‐Hartman, V. Paul Doria‐Rose, (unknown), Christine Neslund‐Dudas, Caryn Oshiro, Roger Y. Kim, Jennifer Elston Lafata, Stacey Honda, Debra P. Ritzwoller, (unknown), Nandita Mitra, Robert T. Greenlee	22
5	Colorectal Cancer Screening and Social Needs 2024 ·The Journal of the American Board of Family Medicine ·(unknown), (unknown), (unknown), Beverly B. Green, Robert S. Nocon, Gloria D. Coronado, Erin E. Hahn, Stacey Honda, (unknown), Theodore R. Levin, Claudia Steiner, Quyen Ngo‐Metzger	1
6	Smoking status and the association between patient-level factors and survival among lung cancer patients 2023 ·JNCI Journal of the National Cancer Institute ·Nikki M. Carroll, Andrea N. Burnett‐Hartman, Katharine A. Rendle, Christine Neslund‐Dudas, Robert T. Greenlee, Stacey Honda, Anil Vachani, Debra P. Ritzwoller	2
7	Percentage Up to Date With Chest Computed Tomography Among Those Eligible for Lung Cancer Screening 2023 ·American Journal of Preventive Medicine ·Andrea N. Burnett‐Hartman, Nikki M. Carroll, Jennifer M. Croswell, Robert T. Greenlee, Stacey Honda, Christine Neslund‐Dudas, Roger Y. Kim, Katharine A. Rendle, Anil Vachani, Debra P. Ritzwoller	3
8	Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium 2023 ·Journal of General Internal Medicine ·Christine Neslund‐Dudas, Amy Tang, (unknown), Katie R. Zarins, Pin Li, Michael Simoff, Jennifer Elston Lafata, Katharine A. Rendle, (unknown), Stacey Honda, Caryn Oshiro, (unknown), Robert T. Greenlee, Anil Vachani, Debra P. Ritzwoller	8
9	Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancer 2023 ·Cancer Treatment and Research Communications ·Nikki M. Carroll, (unknown), Andrea N. Burnett‐Hartman, Robert T. Greenlee, Stacey Honda, Christine Neslund‐Dudas, Katharine A. Rendle, Anil Vachani, Debra P. Ritzwoller	1
10	Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study 2022 ·Annals of the American Thoracic Society ·Roger Y. Kim, Katharine A. Rendle, Nandita Mitra, (unknown), Christine Neslund‐Dudas, Robert T. Greenlee, Andrea N. Burnett‐Hartman, Stacey Honda, Michael Simoff, Marilyn M. Schapira, Jennifer M. Croswell, Rafael Meza, Debra P. Ritzwoller, Anil Vachani	39
11	Reusing a prepaid health plan’s fecal immunochemical tests for microbiome associations with colorectal adenoma 2022 ·Scientific Reports ·James J. Goedert, (unknown), (unknown), Timothy B. Frankland, Rashmi Sinha, Gieira S. Jones, Yunhu Wan, Jacques Ravel, Ni Zhao, Stacey Honda	1
12	Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose Computed Tomography Screening 2022 ·Journal of Thoracic Oncology ·Anil Vachani, Nikki M. Carroll, Michael Simoff, Christine Neslund‐Dudas, Stacey Honda, Robert T. Greenlee, Katharine A. Rendle, Andrea N. Burnett‐Hartman, Debra P. Ritzwoller	38
13	Medical chart validation of inpatient diagnosis codes for transfusion‐related acute lung injury 2013‐2015 2021 ·Transfusion ·Candace C. Fuller, Vinod E. Nambudiri, (unknown), Lesley H. Curtis, Mayura Shinde, (unknown), Michele Johnson, Jason Hickok, Stacey Honda, Heba M. Ismail, Richard M. Kaufman, (unknown), (unknown), (unknown), Russell E. Poland, (unknown), (unknown), Salim Surani, Meghan A. Baker	5
14	Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: The PROSPR Consortium 2021 ·Annals of the American Thoracic Society ·Andrea N. Burnett‐Hartman, Nikki M. Carroll, Stacey Honda, (unknown), Nandita Mitra, Christine Neslund‐Dudas, (unknown), Katharine A. Rendle, Mitchell D. Schnall, Anil Vachani, Debra P. Ritzwoller	11
15	Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor 2016 ·Human Pathology ·Lei Zhang, David Shimizu, Jeffrey Killeen, Stacey Honda, (unknown), (unknown), Fritz Lin, Beverly Wang, Edwin S. Monuki, Michele Carbone	1
16	Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems 2015 ·Healthcare ·Eric B. Larson, (unknown), (unknown), Gloria D. Coronado, Lynn DeBar, Laura M. Dember, Stacey Honda, Susan S. Huang, Jeffrey G. Jarvik, Christine Nelson, Edward Septimus, Greg Simon, Karin Johnson	12
17	Real-Time Polymerase Chain Reaction Detection of Angiostrongylus cantonensis DNA in Cerebrospinal Fluid from Patients with Eosinophilic Meningitis 2015 ·American Journal of Tropical Medicine and Hygiene ·Yvonne Qvarnström, Maniphet Xayavong, Ana Cristina Arámburu da Silva, Sarah Y. Park, A. Christian Whelen, (unknown), (unknown), Stacey Honda, (unknown), Paul Kitsutani, Nora Chea, Heng Seng, Stuart Johnson, Carlos Graeff-Teixeira, LeAnne M. Fox, Alexandre J. da Silva	60
18	The Kaiser Permanente Biobank: A Multiregion Resource Linking Specimens and Electronic Medical Records for Broad Research in an Integrated Health Care Delivery System 2015 ·Journal of patient-centered research and reviews ·Heather Spencer Feigelson, Lisa Croen, Katrina A.B. Goddard, Stacey Honda, Michael A. Horberg, Corinna Koebnick, Ashli Owen‐Smith, (unknown), Catherine Schaefer, Carol P. Somkin, Karen M. Emmons	1
19	Congestive heart failure: a case of protein misfolding. 2014 ·PubMed ·Chung‐Eun Ha, Nadhipuram V. Bhagavan, (unknown), S. K. Chan, Nguyễn Văn Huy, Carlos N. Rios, Stacey Honda	1
20	Role of cardiac troponin I in the evaluation of myocardial injury 1998 ·Journal of Clinical Laboratory Analysis ·Nadhipuram V. Bhagavan, (unknown), Stacey Honda, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact